US2014336139A1PendingUtilityA1

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

71
Assignee: GALDERMA SAPriority: Apr 24, 2003Filed: Jul 22, 2014Published: Nov 13, 2014
Est. expiryApr 24, 2023(expired)· nominal 20-yr term from priority
A61K 31/35A61K 9/107A61K 31/7048A61P 17/08A61P 17/10A61P 17/00A61K 9/0014
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for the treatment of common acne, seborrheic dermatitis, perioral dermatitis, an acneform rash, transient acantholytic dermatosis or acne necrotica milliaris, comprising topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin, said topical pharmaceutical composition being formulated as an emulsion, the topical pharmaceutical emulsion comprising:
 an oily phase comprising dimethicone, cyclomethicone, isopropyl palmitate and/or isopropyl myristate, said oily phase further comprising fatty substances selected from the group consisting of cetostearyl alcohol, cetyl alcohol, stearyl alcohol, stearic acid, palmitostearic acid and self-emulsifiable wax;   at least one surfactant-emulsifier selected from the group consisting of glyceryl/PEG100 stearate, sorbitan monostearate, sorbitan palmitate, Steareth-20, Steareth-2, Steareth-21 and Ceteareth-20;   ivermectin;   a mixture of solvents and/or propenetrating agents selected from the group consisting of propylene glycol, oleyl alcohol, phenoxyethanol and glyceryl triacetate;   one or more gelling agents selected from the group consisting of carbomers, cellulose gelling agents, xanthan gums, aluminum magnesium silicates but excluding aluminum magnesium silicate/titanium dioxide/silica, guar gums, polyacrylamides and modified starches; and   water;   said emulsion being chemically stable over a period of time of 8 weeks.   
     
     
         2 .- 38 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.